Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-08-004642
Filing Date
2008-03-12
Accepted
2008-03-12 17:15:10
Documents
7
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v36510e10vk.htm 10-K 1009937
2 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES v36510exv12.htm EX-12 14702
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM v36510exv23w1.htm EX-23.1 1775
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER v36510exv31w1.htm EX-31.1 8903
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER v36510exv31w2.htm EX-31.2 8860
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER v36510exv32.htm EX-32 5098
7 GRAPHIC v36510v3651001.gif GRAPHIC 4798
  Complete submission text file 0000950134-08-004642.txt   1057308
Mailing Address
Business Address 3005 FIRST AVENUE SEATTLE WA 98121 206254545
DENDREON CORP (Filer) CIK: 0001107332 (see all company filings)

EIN.: 223203193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30681 | Film No.: 08684229
SIC: 2834 Pharmaceutical Preparations